Public EUDAMED Search

EUDAMED Device Search

A readable public search layer for EUDAMED device, manufacturer, UDI, EMDN and risk class data.

Last updated

23.09.2026 04:15

Sync status

Successful

Device

3540243

Actor

47787

Certificate

3399

Active filter:EMDN:G04

1000+ device results listed.

Page 10 / 50

Class IIIMDR 2017/745On the marketSingle use
Manufacturer
HÄLSA Pharma GmbH
Manufacturer SRN
DE-MF-000007407
UDI-DI
04251778107231
Basic UDI-DI
42517781MD339D8
Reference
308572391
EMDN
G0401
EMDN description
ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country
-
Safety summary (SSCP/SSP)
SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative
-
Last updated
30.07.2026 02:29
Class IIIMDR 2017/745On the marketSingle use
Manufacturer
HÄLSA Pharma GmbH
Manufacturer SRN
DE-MF-000007407
UDI-DI
04251778107248
Basic UDI-DI
42517781MD339D8
Reference
308572373
EMDN
G0401
EMDN description
ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country
-
Safety summary (SSCP/SSP)
SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative
-
Last updated
30.07.2026 02:29
Class IIIMDR 2017/745On the marketSingle use
Manufacturer
HÄLSA Pharma GmbH
Manufacturer SRN
DE-MF-000007407
UDI-DI
04251778107255
Basic UDI-DI
42517781MD339D8
Reference
308573308
EMDN
G0401
EMDN description
ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country
-
Safety summary (SSCP/SSP)
SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative
-
Last updated
30.07.2026 02:29
Class IIIMDR 2017/745On the marketSingle use
Manufacturer
HÄLSA Pharma GmbH
Manufacturer SRN
DE-MF-000007407
UDI-DI
04251778107262
Basic UDI-DI
42517781MD339D8
Reference
308573391
EMDN
G0401
EMDN description
ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country
-
Safety summary (SSCP/SSP)
SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative
-
Last updated
30.07.2026 02:29
Class IIIMDR 2017/745On the marketSingle use
Manufacturer
HÄLSA Pharma GmbH
Manufacturer SRN
DE-MF-000007407
UDI-DI
04251778107279
Basic UDI-DI
42517781MD339D8
Reference
308573373
EMDN
G0401
EMDN description
ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country
-
Safety summary (SSCP/SSP)
SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative
-
Last updated
30.07.2026 02:29
Class IIIMDR 2017/745On the marketSingle use
Manufacturer
HÄLSA Pharma GmbH
Manufacturer SRN
DE-MF-000007407
UDI-DI
04251778107316
Basic UDI-DI
42517781MD339D8
Reference
572302
EMDN
G0401
EMDN description
ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country
-
Safety summary (SSCP/SSP)
SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative
-
Last updated
30.07.2026 02:29
Class IIIMDR 2017/745On the marketSingle use
Manufacturer
HÄLSA Pharma GmbH
Manufacturer SRN
DE-MF-000007407
UDI-DI
04251778107323
Basic UDI-DI
42517781MD339D8
Reference
573302
EMDN
G0401
EMDN description
ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country
-
Safety summary (SSCP/SSP)
SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative
-
Last updated
30.07.2026 02:29
Class IIIMDR 2017/745On the marketSingle use
Manufacturer
HÄLSA Pharma GmbH
Manufacturer SRN
DE-MF-000007407
UDI-DI
04251778107330
Basic UDI-DI
42517781MD339D8
Reference
1571302
EMDN
G0401
EMDN description
ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country
-
Safety summary (SSCP/SSP)
SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative
-
Last updated
30.07.2026 02:29
Class IIIMDR 2017/745On the marketSingle use
Manufacturer
HÄLSA Pharma GmbH
Manufacturer SRN
DE-MF-000007407
UDI-DI
04251778107347
Basic UDI-DI
42517781MD339D8
Reference
574302
EMDN
G0401
EMDN description
ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country
-
Safety summary (SSCP/SSP)
SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative
-
Last updated
30.07.2026 02:29
Class IIIMDR 2017/745On the marketSingle use
Manufacturer
HÄLSA Pharma GmbH
Manufacturer SRN
DE-MF-000007407
UDI-DI
04251778107354
Basic UDI-DI
42517781MD339D8
Reference
301572302
EMDN
G0401
EMDN description
ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country
-
Safety summary (SSCP/SSP)
SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative
-
Last updated
30.07.2026 02:29
Class IIIMDR 2017/745On the marketSingle use
Manufacturer
HÄLSA Pharma GmbH
Manufacturer SRN
DE-MF-000007407
UDI-DI
04251778107361
Basic UDI-DI
42517781MD339D8
Reference
301573302
EMDN
G0401
EMDN description
ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country
-
Safety summary (SSCP/SSP)
SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative
-
Last updated
30.07.2026 02:29
Class IIIMDR 2017/745On the marketSingle use
Manufacturer
HÄLSA Pharma GmbH
Manufacturer SRN
DE-MF-000007407
UDI-DI
04251778107378
Basic UDI-DI
42517781MD339D8
Reference
313571302
EMDN
G0401
EMDN description
ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country
-
Safety summary (SSCP/SSP)
SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative
-
Last updated
30.07.2026 02:29
Class IIIMDR 2017/745On the marketSingle use
Manufacturer
HÄLSA Pharma GmbH
Manufacturer SRN
DE-MF-000007407
UDI-DI
04251778107385
Basic UDI-DI
42517781MD339D8
Reference
301574302
EMDN
G0401
EMDN description
ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country
-
Safety summary (SSCP/SSP)
SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative
-
Last updated
30.07.2026 02:29
Class IIIMDR 2017/745On the marketSingle use
Manufacturer
HÄLSA Pharma GmbH
Manufacturer SRN
DE-MF-000007407
UDI-DI
04251778107392
Basic UDI-DI
42517781MD339D8
Reference
302572302
EMDN
G0401
EMDN description
ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country
-
Safety summary (SSCP/SSP)
SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative
-
Last updated
30.07.2026 02:29
Class IIIMDR 2017/745On the marketSingle use
Manufacturer
HÄLSA Pharma GmbH
Manufacturer SRN
DE-MF-000007407
UDI-DI
04251778107408
Basic UDI-DI
42517781MD339D8
Reference
302573302
EMDN
G0401
EMDN description
ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country
-
Safety summary (SSCP/SSP)
SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative
-
Last updated
30.07.2026 02:29
Class IIIMDR 2017/745On the marketSingle use
Manufacturer
HÄLSA Pharma GmbH
Manufacturer SRN
DE-MF-000007407
UDI-DI
04251778107415
Basic UDI-DI
42517781MD339D8
Reference
314571302
EMDN
G0401
EMDN description
ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country
-
Safety summary (SSCP/SSP)
SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative
-
Last updated
30.07.2026 02:29
Class IIIMDR 2017/745On the marketSingle use
Manufacturer
HÄLSA Pharma GmbH
Manufacturer SRN
DE-MF-000007407
UDI-DI
04251778107422
Basic UDI-DI
42517781MD339D8
Reference
302574302
EMDN
G0401
EMDN description
ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country
-
Safety summary (SSCP/SSP)
SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative
-
Last updated
30.07.2026 02:29
Class IIIMDR 2017/745On the marketSingle use
Manufacturer
HÄLSA Pharma GmbH
Manufacturer SRN
DE-MF-000007407
UDI-DI
04251778107477
Basic UDI-DI
42517781MD339D8
Reference
304572302
EMDN
G0401
EMDN description
ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country
-
Safety summary (SSCP/SSP)
SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative
-
Last updated
30.07.2026 02:29
Class IIIMDR 2017/745On the marketSingle use
Manufacturer
HÄLSA Pharma GmbH
Manufacturer SRN
DE-MF-000007407
UDI-DI
04251778107484
Basic UDI-DI
42517781MD339D8
Reference
304573302
EMDN
G0401
EMDN description
ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country
-
Safety summary (SSCP/SSP)
SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative
-
Last updated
30.07.2026 02:29
Class IIIMDR 2017/745On the marketSingle use
Manufacturer
HÄLSA Pharma GmbH
Manufacturer SRN
DE-MF-000007407
UDI-DI
04251778107491
Basic UDI-DI
42517781MD339D8
Reference
316751302
EMDN
G0401
EMDN description
ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country
-
Safety summary (SSCP/SSP)
SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative
-
Last updated
30.07.2026 02:29